#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Intracranial germ cell tumour Leiomyosarcoma metastatic Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Acute respiratory distress syndrome Marginal zone lymphoma refractory Pulmonary hypertension Uterine leiomyosarcoma Isodicentric chromosome 15 syndrome Systemic candida Carcinoid tumour Sickle cell disease Thrombocytosis Hypocalcaemia Hairy cell leukaemia Leukocyte adhesion deficiency type I More trials…

    Learn about Rare Diseases

    Haemophilia A with anti factor VIII – Basic Information IgA nephropathy Mantle cell lymphoma stage IV – Trials in Disease Gastrointestinal stromal tumour – Life with Disease Langerhans’ cell histiocytosis – Trials in Disease Hereditary optic atrophy – Life with Disease Basal cell naevus syndrome Hereditary motor and sensory neuropathy – Diagnostics Lysosomal storage disorder – Basic Information Crigler-Najjar syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nanatinostat Doxycycline Monohydrate Imlifidase ZUNIBERGENE ROCPARVOVEC Enfuvirtide Quercus Robur Pollen Extract Isoleucine VERCIRNON Sertindole Imidapril Hydrochloride Lorazepam Rocatinlimab Dorzolamide Magnesium Hydroxide Olaptesed Pegol [68GA]GA-NOTA-AE105 Bezafibrate Sodium Iodide Posenacaftor Gskvx000000017033 More therapies…

    Learn about Your Condition

    Cholangitis sclerosing Metastatic neoplasm Soft tissue sarcoma Skin bacterial infection Hepatic fibrosis Tissue anoxia Gastrointestinal melanoma Prostate cancer metastatic Duchenne muscular dystrophy Muscle spasticity Toxicity to various agents Neuropathy peripheral Aortic stenosis Angiosarcoma metastatic Myocarditis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Use of Plasma Rich in Growth Factors for Treating Foot Ulcers in Diabetic Patients with Peripheral Arterial Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Diabetic foot
    Investigated Drugs:
    • Platelet Concentrate
    Spain

  • Study of Nivolumab for Patients with Metastatic Solid Tumors and Leptomeningeal Disease

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Metastases to meninges
    Investigated Drugs:
    • Nivolumab
    Germany

  • Study on the Safety and Effectiveness of Apixaban and Warfarin for Patients with End-Stage Renal Disease on Peritoneal Dialysis and Atrial Fibrillation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Warfarin
    • Warfarin Sodium
    • Apixaban
    France

  • Study on Pelacarsen for Slowing Calcific Aortic Valve Stenosis in Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Aortic valve stenosis
    Investigated Drugs:
    • Pelacarsen
    Austria Belgium Czechia Denmark France Germany +4

  • Safety Monitoring of Crizotinib for Patients Continuing from Previous Studies

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Crizotinib
    Italy

  • Study on Preventing Hypothyroidism in Patients with Medulloblastoma and Pediatric Lymphoma Using Levothyroxine During Radiation Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Medulloblastoma
    • Hodgkin’s disease
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • Levothyroxine
    Italy
Previous Page
1 … 491 492 493 494 495 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!